These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 9062583

  • 1. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis.
    Decker HJ, Weidt EJ, Brieger J.
    Cancer Genet Cytogenet; 1997 Jan; 93(1):74-83. PubMed ID: 9062583
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC, Prowse AH, Affara NA, Buys CH, Maher ER.
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [Abstract] [Full Text] [Related]

  • 3. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.
    Olschwang S, Richard S, Boisson C, Giraud S, Laurent-Puig P, Resche F, Thomas G.
    Hum Mutat; 1998 Jul; 12(6):424-30. PubMed ID: 9829912
    [Abstract] [Full Text] [Related]

  • 4. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B.
    Cancer Surv; 1995 Jul; 25():219-32. PubMed ID: 8718521
    [Abstract] [Full Text] [Related]

  • 5. Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene.
    Hes F, Zewald R, Peeters T, Sijmons R, Links T, Verheij J, Matthijs G, Leguis E, Mortier G, van der Torren K, Rosman M, Lips C, Pearson P, van der Luijt R.
    Hum Genet; 2000 Apr; 106(4):425-31. PubMed ID: 10830910
    [Abstract] [Full Text] [Related]

  • 6. Detection of a germline mutation and somatic homozygous loss of the von Hippel-Lindau tumor-suppressor gene in a family with a de novo mutation. A combined genetic study, including cytogenetics, PCR/SSCP, FISH, and CGH.
    Decker HJ, Neuhaus C, Jauch A, Speicher M, Ried T, Bujard M, Brauch H, Störkel S, Stöckle M, Seliger B, Huber C.
    Hum Genet; 1996 Jun; 97(6):770-6. PubMed ID: 8641695
    [Abstract] [Full Text] [Related]

  • 7. von Hippel-Lindau disease.
    Couch V, Lindor NM, Karnes PS, Michels VV.
    Mayo Clin Proc; 2000 Mar; 75(3):265-72. PubMed ID: 10725953
    [Abstract] [Full Text] [Related]

  • 8. [Von Hippel-Lindau disease].
    Shuin T, Ashida S, Yao M, Kanno H.
    Nihon Rinsho; 2000 Jul; 58(7):1448-54. PubMed ID: 10921322
    [Abstract] [Full Text] [Related]

  • 9. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH.
    Oncogene; 2000 Nov 16; 19(48):5435-43. PubMed ID: 11114720
    [Abstract] [Full Text] [Related]

  • 10. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
    Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG.
    Hum Mol Genet; 2001 May 01; 10(10):1019-27. PubMed ID: 11331612
    [Abstract] [Full Text] [Related]

  • 11. Genotype-phenotype correlation in von Hippel-Lindau syndrome.
    Friedrich CA.
    Hum Mol Genet; 2001 Apr 01; 10(7):763-7. PubMed ID: 11257110
    [Abstract] [Full Text] [Related]

  • 12. Multiple intracerebral haemangioblastomas in identical twins with von Hippel-Lindau disease--a clinical and molecular study.
    Sobottka SB, Frank S, Hampl M, Schackert HK, Schackert G.
    Acta Neurochir (Wien); 1998 Apr 01; 140(3):281-5. PubMed ID: 9638266
    [Abstract] [Full Text] [Related]

  • 13. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
    Kaelin WG.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
    [Abstract] [Full Text] [Related]

  • 14. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
    Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M, Pack S, Hurley K, Andrey C, Klausner R, Linehan WM.
    Hum Mutat; 1998 Sep 15; 12(6):417-23. PubMed ID: 9829911
    [Abstract] [Full Text] [Related]

  • 15. Third International Meeting on von Hippel-Lindau disease.
    Zbar B, Kaelin W, Maher E, Richard S.
    Cancer Res; 1999 May 01; 59(9):2251-3. PubMed ID: 10232616
    [Abstract] [Full Text] [Related]

  • 16. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M, da Silva NF, Clifford SC, Morris MR, Wiesener MS, Eckardt KU, Houlston RS, Richards FM, Latif F, Maher ER.
    Cancer Res; 2002 Jul 01; 62(13):3803-11. PubMed ID: 12097293
    [Abstract] [Full Text] [Related]

  • 17. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H, De Krijger RR, van der Harst E, Abbou M, IJzendoorn Y, Komminoth P, Dinjens WN.
    Int J Cancer; 2003 Jun 10; 105(2):190-5. PubMed ID: 12673678
    [Abstract] [Full Text] [Related]

  • 18. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
    Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HP, Laidlaw J, Li FP.
    Am J Hum Genet; 1994 Dec 10; 55(6):1092-102. PubMed ID: 7977367
    [Abstract] [Full Text] [Related]

  • 19. Von Hippel-Lindau syndrome. A pleomorphic condition.
    Friedrich CA.
    Cancer; 1999 Dec 01; 86(11 Suppl):2478-82. PubMed ID: 10630173
    [Abstract] [Full Text] [Related]

  • 20. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.
    Siemeister G, Weindel K, Mohrs K, Barleon B, Martiny-Baron G, Marmé D.
    Cancer Res; 1996 May 15; 56(10):2299-301. PubMed ID: 8625303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.